McKesson Co. (NYSE:MCK) Shares Purchased by Simon Quick Advisors LLC

Simon Quick Advisors LLC grew its stake in shares of McKesson Co. (NYSE:MCK) by 15.4% in the fourth quarter, HoldingsChannel reports. The fund owned 666 shares of the company’s stock after buying an additional 89 shares during the quarter. Simon Quick Advisors LLC’s holdings in McKesson were worth $380,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new stake in McKesson in the third quarter valued at approximately $29,000. Wolff Wiese Magana LLC boosted its holdings in shares of McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after purchasing an additional 52 shares during the last quarter. RPg Family Wealth Advisory LLC purchased a new stake in shares of McKesson during the 3rd quarter valued at $31,000. ORG Wealth Partners LLC acquired a new stake in shares of McKesson during the 3rd quarter worth $40,000. Finally, Bruce G. Allen Investments LLC raised its position in shares of McKesson by 51.9% in the 4th quarter. Bruce G. Allen Investments LLC now owns 82 shares of the company’s stock worth $47,000 after buying an additional 28 shares during the period. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the sale, the executive vice president now owns 864 shares in the company, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.11% of the stock is currently owned by insiders.

McKesson Price Performance

Shares of McKesson stock opened at $597.31 on Friday. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $637.51. The company has a market capitalization of $75.82 billion, a PE ratio of 30.93, a P/E/G ratio of 1.27 and a beta of 0.52. The business has a 50-day moving average of $593.20 and a 200-day moving average of $561.23.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The firm had revenue of $93.65 billion during the quarter, compared to analyst estimates of $89.33 billion. During the same quarter last year, the firm earned $6.23 EPS. McKesson’s quarterly revenue was up 21.3% on a year-over-year basis. On average, equities analysts expect that McKesson Co. will post 32.73 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were issued a $0.71 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 annualized dividend and a yield of 0.48%. McKesson’s dividend payout ratio is presently 14.71%.

Wall Street Analyst Weigh In

MCK has been the topic of a number of research reports. Morgan Stanley raised their price objective on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. StockNews.com upgraded shares of McKesson from a “hold” rating to a “buy” rating in a report on Wednesday, November 6th. Bank of America decreased their price objective on shares of McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Citigroup dropped their price objective on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a research report on Friday, January 10th. Finally, Wells Fargo & Company lifted their target price on shares of McKesson from $535.00 to $641.00 and gave the company an “equal weight” rating in a report on Friday, December 13th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $646.14.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.